Matthias Kohl

Title: Matthias Kohl: Innovator in Asphyxia Diagnosis and Treatment

Introduction

Matthias Kohl is a notable inventor based in Rottweil, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of asphyxia. With a total of 2 patents to his name, his work focuses on innovative methods for diagnosing and treating asphyxia and related disorders.

Latest Patents

Kohl's latest patents include a groundbreaking method for in vitro diagnosing asphyxia. This method involves estimating the duration of hypoxia in patients subjected to asphyxia. Additionally, it provides a way to monitor normoxic, hypoxic, and hyperoxic conditions, as well as normobaric and hyperbaric oxygen therapy. The method quantitatively detects a variety of asphyxia-specific endogenous compounds in biological samples. These compounds include biogenic amines, carnitine-derived compounds, amino acids, bile acids, carboxylic acids, eicosanoids, lipids, cholesterol precursors, cholesterol metabolites, prostanoids, and sugars.

Career Highlights

Matthias Kohl is currently associated with Infandx AG, where he continues to develop innovative solutions in medical diagnostics. His work has garnered attention for its potential to improve patient outcomes in critical situations involving asphyxia.

Collaborations

Kohl collaborates with esteemed colleagues such as Therese Koal and Hans-Peter Deigner. Their combined expertise enhances the research and development efforts at Infandx AG.

Conclusion

Matthias Kohl's contributions to the field of asphyxia diagnosis and treatment exemplify the impact of innovation in medical science. His patents reflect a commitment to advancing healthcare through technology and research.